The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensus

˜The œLancet. Gastroenterology & hepatology 2026 Open access

Read full text
Authors: Jeremy F Cobbold, Hamish Miller, Kate Hallsworth, Pinelopi Manousou, Thomas Marjot, Michael E D Allison, Quentin M Anstee, MJ Armstrong, Leah Avery, Vian Azzu, P N Brennan, Christopher D Byrne
+27 more Tessa Cacciottolo, Lynsey Corless, D Forton, Timothy Hardy, Vanessa Hebditch, Helen Jarvis, Wenhao Li, Dina Mansour, Stuart McPherson, Yensiew Miao, Joanne Morling, Ashis Mukhopadhya, Benjamin Mullish, Richard Parker, Imran Patanwala, Jay Patel, Michael Pavlides, Tina Reinson, Ian Rowe, Francesca Saffioti, Faisal Shaikh, Ankur Srivastava, Nwe Ni Than, Emmanuel Tsochatzis, Edvard Volcek, Jeremy Tomlinson, William Alazawi
DOI: 10.1016/s2468-1253(26)00077-4
Cited by: 3
References: 87

Fields of Study & Subjects

Liver Disease Diagnosis and Treatment Liver Disease and Transplantation Drug-Induced Hepatotoxicity and Protection

Publication details

Journal / source
˜The œLancet. Gastroenterology & hepatology
Publisher
Elsevier BV
Volume
11
Issue
7
Pages
616–626
Publication date
1 May 2026
Language
EN